Condition
Oropharynx Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Oropharynx Squamous Cell Carcinoma clinical trials that are recruiting, at sites in 3 countries (most in United States (4), France (1), Sweden (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Oropharynx Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Sacituzumab govitecan plus cetuximab for recurrent or metastatic head and neck squamous cell cancer | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Jul 14, 2025 |
| New blood test to reduce radiation in HPV-related throat cancer treatment | Phase 2 | Baltimore, Maryland and 4 other locations | Recruiting | Oct 18, 2023 |
| Monitoring HPV DNA in patients with throat cancer | — | Lund, Skåne County | Recruiting | Dec 14, 2022 |
| New method to monitor HPV16-related throat cancer recurrence | Phase 2 | Saint-Denis, La Réunion and 15 other locations | Recruiting | Oct 17, 2022 |
| Detecting oral and throat cancers using a saliva test | — | New York, New York | Recruiting | Jul 11, 2022 |
| Observing HPV DNA and genetic markers in oropharyngeal cancer | — | Rochester, Minnesota and 2 other locations | Recruiting | Sep 25, 2020 |
All recruiting trials (6)
-
Sacituzumab govitecan plus cetuximab for recurrent or metastatic head and neck squamous cell cancer
This trial will test whether combining sacituzumab govitecan with cetuximab works and is safe for people whose head and neck squamous cell cancer has returned or spread after prior immunotherapy.
-
New blood test to reduce radiation in HPV-related throat cancer treatment
This study is testing a new blood test to see if it can help identify patients with HPV-related throat cancer who might not need radiation after surgery, aiming to reduce side effects while keeping survival rates high.
-
Monitoring HPV DNA in patients with throat cancer
This study is testing if checking for HPV DNA in the blood of throat cancer patients can help doctors spot any remaining cancer or recurrences after treatment.
-
New method to monitor HPV16-related throat cancer recurrence
This study is testing if measuring HPV16 DNA in the blood can help doctors better monitor throat cancer patients for signs of recurrence, so they can provide more personalized follow-up care.
-
Detecting oral and throat cancers using a saliva test
This study is testing a saliva test to see if it can help detect oral and throat cancers early in people, including those who are healthy and those with existing conditions.
-
Observing HPV DNA and genetic markers in oropharyngeal cancer
This study is testing if checking for certain gene changes and HPV DNA in the blood can help predict if oropharyngeal cancer will come back in newly diagnosed patients.
Related topics
Quick answers
How many Oropharynx Squamous Cell Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (4 trials), France (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.